HALO vs STZ · P/E 15, rev $857.7M vs P/E 14, rev $9.14B
Halozyme Therapeutics Inc (HALO) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
HALO currently screens at market cap $7.10B and trailing P/E 15.3. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the HALO and STZ stock pages for the full models.
Not investment advice.